NewsPulse
← All stories
Science2 days ago· 1 min read

New AI-Powered Blood Test Offers Early Warning of Heart and Circulation Problems

Researchers have developed CardiOmicScore, an AI-powered blood test that can detect serious heart and circulation problems much earlier than conventional methods, using advanced analysis of blood protein markers to identify disease risk before symptoms appear.

CardiOmicScore: A Breakthrough in Cardiac Diagnostics

A new AI-powered blood test developed by researchers at the University of Hong Kong, called CardiOmicScore, could give people a remarkably early warning of serious heart and circulation problems. This advance, announced on July 19, 2026, represents a significant step forward in preventive cardiology and early disease detection.

How the Test Works

The CardiOmicScore utilizes artificial intelligence to analyze blood protein biomarkers and identify patterns associated with cardiovascular disease. By combining machine learning with proteomic analysis, the test can detect subtle changes in blood composition that precede clinical manifestations of heart disease. This approach allows physicians to identify at-risk patients before they develop acute symptoms or major complications.

Clinical Implications and Potential Impact

An experimental vaccine aimed at preventing fentanyl overdoses showed promise in an early-stage clinical trial, demonstrating how novel therapeutic approaches are expanding beyond traditional treatments for major health challenges. Similarly, early detection technologies like CardiOmicScore could transform preventive care strategies by enabling interventions before disease becomes advanced and difficult to treat.

Future of Precision Medicine

The development of AI-powered diagnostic tools represents a broader shift in medicine toward precision and personalized approaches. Early detection enables earlier intervention, potentially reducing hospitalizations, improving outcomes, and lowering healthcare costs. This test exemplifies how computational analysis of biological data can uncover risk patterns invisible to traditional diagnostic methods.

Sources